|
Volumn 94, Issue 5, 2013, Pages 570-573
|
Integration of pharmacometabolomic and pharmacogenomic approaches reveals novel insights into antiplatelet therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
DRUG METABOLITE;
ARTICLE;
CLINICAL RESEARCH;
HUMAN;
METABOLOMICS;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
ASPIRIN;
CARDIOVASCULAR DISEASES;
HUMANS;
METABOLOMICS;
PHARMACOGENETICS;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
|
EID: 84886727080
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2013.153 Document Type: Article |
Times cited : (35)
|
References (5)
|